CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Manan M. Nayak

OPENALEX: A5086707185↗ORCID: 0000-0003-4979-8343↗

Affiliations

Organizations

Dana-Farber Cancer Instituteauthorship · US Dana-Farber/Harvard Cancer Centerauthorship · US Harvard Universityauthorship · US

Public evidence

4 connected articles

Cannabis use among cancer survivors before and during the COVID-19 pandemic, 2019-20212023 · PubMed Central Open Access <i>Letter to the Editor:</i> The Role of Cannabidiol in Cancer Care: Oncologist and Cancer Patient Perspectives.2023 · Europe PMC Dispensary personnel's views and experiences regarding oncologic cannabis and the counsel they offer adults with cancer.2023 · PubMed Central Open Access Medical cannabis-related stigma: cancer survivors' perspectives.2022 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Manan M. Nayak - Medical Cannabis Research Engine